{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:13:55Z","timestamp":1754162035608,"version":"3.41.2"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ventricular arrhythmia is a common complication of acute myocardial infarction (AMI). The Arg389Gly polymorphism of the \u03b21-adrenergic receptor genotype may affect AMI patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>Patients diagnosed with AMI were included in this study. Clinical data were obtained from the patient\u2019s medical history, and genotypes were retrieved from laboratory test reports. ECG data were recorded daily. Data analysis was performed using SPSS 20.0, and differences were deemed statistically significant at <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>In the final study, 213 patients were included. The proportions of the Arg389Arg, Arg389Gly, and Gly389Gly genotypes were 65.7%, 21.6%, and 12.7%, respectively. Patients with the Arg389Arg genotype exhibited significantly elevated cardiac troponin T (cTnT) and pro-BNP levels compared to the Arg389Gly and Gly389Gly genotypes [cTnT: 4.00\u2005\u00b1\u20052.43\u2005ng\/ml versus 2.82\u2005\u00b1\u20051.82\u2005ng\/ml, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.012; pro-BNP: 1942.37 (1223.194, 206.59) pg\/ml versus 1604.57 (798.05, 1884.79) pg\/ml, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.005]. Patients with the Arg389Arg genotype exhibited a lower ejection fraction than those with the Gly389Gly genotype (54.13\u2005\u00b1\u20054.94% vs. 57.11\u2005\u00b1\u20052.87%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). Patients homozygous for Arg389Arg exhibited a higher incidence of ventricular tachycardia and a greater proportion of premature ventricular contraction (PVC) compared to patients homozygous for Gly389Gly (ventricular tachycardia: 19.29% vs. 0.00%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.009; PVC: 70.00% vs. 40.74%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.003).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The Arg389Arg genotype is associated with greater myocardial damage, impaired cardiac function, and an increased probability of ventricular arrhythmia in AMI patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001246","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T03:00:53Z","timestamp":1682564453000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effect of \u03b21-adrenergic receptor gene polymorphism on ventricular arrhythmia and prognosis after myocardial infarction"],"prefix":"10.1097","volume":"34","author":[{"given":"Tao","family":"Ran","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital"},{"name":"Department of Cardiology, Minhang Hospital, Fudan University, Shanghai, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong","family":"Xiaojuan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Minhang Hospital, Fudan University, Shanghai, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Qingxing","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Minhang Hospital, Fudan University, Shanghai, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Yanling","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Minhang Hospital, Fudan University, Shanghai, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Minhang Hospital, Fudan University, Shanghai, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Wenqing","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"R1-20250729","first-page":"e368","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) trial.","volume":"45","author":"McMurray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)06780-8","article-title":"International union of pharmacology nomenclature of adrenoceptors.","volume":"46","author":"Bylund","year":"1994","journal-title":"Pharmacol Rev"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00001.2010","article-title":"Adrenergic signaling polymorphisms and their impact on cardiovascular disease.","volume":"90","author":"Dorn","year":"2010","journal-title":"Physiol Rev"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1073\/pnas.0509937103","article-title":"A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.","volume":"103","author":"Liggett","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(99)00549-8","article-title":"Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay.","volume":"353","author":"Maqbool","year":"1999","journal-title":"Lancet"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1074\/jbc.274.18.12670","article-title":"A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.","volume":"274","author":"Mason","year":"1999","journal-title":"J Biol Chem"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00392-010-0221-z","article-title":"Functional effects of \u03b21-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without \u03b2-blocker administration.","volume":"100","author":"Kindermann","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.CIR.104.2.187","article-title":"Polymorphism in the beta(1)-adrenergic receptor gene and hypertension.","volume":"104","author":"Bengtsson","year":"2001","journal-title":"Circulation"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"e37659","DOI":"10.1371\/journal.pone.0037659","article-title":"\u03b21 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to \u03b2-blocker therapy and prognosis.","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nm930","article-title":"Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.","volume":"9","author":"Mialet Perez","year":"2003","journal-title":"Nat Med"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11033-011-0771-9","article-title":"A meta-analysis of \u03b21-adrenergic receptor gene polymorphisms in idiopathic dilated cardiomyopathy.","volume":"39","author":"Jin","year":"2012","journal-title":"Mol Biol Rep"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10557-011-6307-7","article-title":"Polymorphisms of the beta adrenergic receptor predict left ventricular remodeling following acute myocardial infarction.","volume":"25","author":"McLean","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1540-8167.2008.01202.x","article-title":"Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.","volume":"19","author":"Ulucan","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R15-20250729","first-page":"2299","article-title":"Beta2-adrenoceptor gene variant Arg16Gly is associated with idiopathic ventricular outflow-tract tachycardia.","volume":"123","author":"Ran","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.119.042434","article-title":"Evaluation and management of premature ventricular complexes.","volume":"141","author":"Marcus","year":"2020","journal-title":"Circulation"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrcardio.2015.121","article-title":"Mechanism, diagnosis, and treatment of outflow tract tachycardia.","volume":"12","author":"Lerman","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/FJC.0000000000000119","article-title":"Association of common polymorphisms in \u03b21-adrenergic receptor with antihypertensive response to carvedilol.","volume":"64","author":"Si","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-8703(03)00110-8","article-title":"Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction.","volume":"146","author":"Iwai","year":"2003","journal-title":"Am Heart J"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcla.20327","article-title":"Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.","volume":"23","author":"Yilmaz","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/10641969509087078","article-title":"The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension?","volume":"17","author":"Julius","year":"1995","journal-title":"Clin Exp Hypertens"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00224-8","article-title":"Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.","volume":"74","author":"Liu","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R23-20250729","first-page":"776","article-title":"Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure.","volume":"34","author":"Yu","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clpt.2006.03.004","article-title":"Beta1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.","volume":"80","author":"Liu","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0009-9236(02)17734-4","article-title":"A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade.","volume":"73","author":"Sofowora","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00008571-200406000-00003","article-title":"Functional responses of human beta1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphisms.","volume":"14","author":"Sandilands","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1540-8167.2006.00509.x","article-title":"Experimental model simulating right ventricular outflow tract tachycardia: a novel technique to initiate RVOT-VT.","volume":"17","author":"Zhou","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1253\/circj.66.723","article-title":"Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy.","volume":"66","author":"Iwai","year":"2002","journal-title":"Circ J"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1475-2840-9-42","article-title":"Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction.","volume":"9","author":"Hakalahti","year":"2010","journal-title":"Cardiovasc Diabetol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:03:57Z","timestamp":1753812237000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001246","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}